「0.1%and」の検索結果
117件：51～55件目を表示
-
General Announcement: February 20, 2025 Senju Pharmaceutical Co., Ltd. Launch and Distribution of “MIEr for BeelineMED” Senju Pharmaceutical Co., Ltd., hereby announces the commercial launch and distr
https://www.senju.co.jp/system/files/content_news/2025-02/ENG_20250220_0.pdf -
お知らせ | 千寿製薬株式会社
December 22, 2025 Obtained manufacturing and marketing approval in Japan for Avarept® Ophthalmic suspension 0.3%, a novel treatment of Dry Eye Disease through Transient Receptor Potential cation chann
https://www.senju.co.jp/english/news/ -
July 16, 2024 General Announcement: Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Senju has successfully completed Phase III clinical trials in Japan for the novel Dry Eye Disease tr
https://www.senju.co.jp/system/files/content_news/2024-07/ENG_20240716.pdf -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
List of Clinical Trial Summaries ※Listed in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Jap
http://www.senju.co.jp/english/rd/trial.html -
Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica
List of Clinical Trial Summaries ※Listed in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Jap
https://www.senju.co.jp/english/rd/trial.html